Quarterly report · Q3
6523.TEDINET S100Q6BS
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥265.1bn | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥94.5bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥340.5bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥252.4bn | 2021-04-01 → 2021-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥86.3bn | 2021-10-01 → 2021-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥21.4bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥10.9bn | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥24.1bn | 2021-04-01 → 2021-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥10.5bn | 2021-10-01 → 2021-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥7.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥4.0bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.0bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥24.9bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥4.8bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥3.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥8.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥18.5bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥3.5bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥3.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥2.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥18.6bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥3.6bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥569.9bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥591.3bn | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥595.1bn | at 2021-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥431.1bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥455.3bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥138.8bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥136.1bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥152.1bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥107.6bn | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥137.9bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥135.4bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥151.5bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥59.4bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥95.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥88.0bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥60.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥6.9bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥51.1bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥36.0bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥11.3bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥12.5bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥9.4bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥32.9bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥7.0bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥106m | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥27.33 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥17.69 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-70.78 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥156.67 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥28.83 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥27.07 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥17.53 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-70.78 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥152.82 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥28.34 | 2021-10-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 24.2% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 22.9% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 25.5% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | ¥1.8bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-12-31 | ¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥13.0bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥83.7bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥83.7bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥19.7bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥80.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥80.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥6.3bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥99.2bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥99.2bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8.5bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥263.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥263.3bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥34.4bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | ¥2.1bn |
| Reconciling Itemsreconciling | revenue external | 2021-04-01 → 2021-12-31 | ¥2.1bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥11.7bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥82.3bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥82.3bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥18.7bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥68.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥68.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥99.6bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥99.6bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥12.4bn |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥250.3bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥250.3bn |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥35.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 934
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in trade payables ope cf IFRS | CurrentYTDDuration | -4581000000 | JPY |
| Increase decrease in retirement benefit liability ope cf IFRS | Prior1YTDDuration | 69000000 | JPY |
| Increase decrease in retirement benefit liability ope cf IFRS | CurrentYTDDuration | 56000000 | JPY |
| Other changes in working capital ope cf IFRS | Prior1YTDDuration | 283000000 | JPY |
| Other changes in working capital ope cf IFRS | CurrentYTDDuration | -6239000000 | JPY |
| Subtotal ope cf IFRS | Prior1YTDDuration | 44276000000 | JPY |
| Subtotal ope cf IFRS | CurrentYTDDuration | 23901000000 | JPY |
| Interest and dividends received ope cf IFRS | Prior1YTDDuration | 516000000 | JPY |
| Interest and dividends received ope cf IFRS | CurrentYTDDuration | 528000000 | JPY |
| Interest paid ope cf IFRS | Prior1YTDDuration | -2354000000 | JPY |
| Interest paid ope cf IFRS | CurrentYTDDuration | -3414000000 | JPY |
| Income taxes paid ope cf IFRS | Prior1YTDDuration | -6424000000 | JPY |
| Income taxes paid ope cf IFRS | CurrentYTDDuration | -14636000000 | JPY |
| Income taxes refund ope cf IFRS | Prior1YTDDuration | 13000000 | JPY |
| Income taxes refund ope cf IFRS | CurrentYTDDuration | 478000000 | JPY |
| Net cash provided by used in operating activities IFRS | Prior1YTDDuration | 36027000000 | JPY |
| Net cash provided by used in operating activities IFRS | CurrentYTDDuration | 6856000000 | JPY |
| Purchase of property plant and equipment and intangible assets inv cf IFRS | Prior1YTDDuration | -8677000000 | JPY |
| Purchase of property plant and equipment and intangible assets inv cf IFRS | CurrentYTDDuration | -7446000000 | JPY |
| Proceeds from sale of property plant and equipment and intangible assets inv cf IFRS | Prior1YTDDuration | 145000000 | JPY |
| Proceeds from sale of property plant and equipment and intangible assets inv cf IFRS | CurrentYTDDuration | 253000000 | JPY |
| Payments for loans receivable inv cf IFRS | Prior1YTDDuration | -601000000 | JPY |
| Payments for loans receivable inv cf IFRS | CurrentYTDDuration | － | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | Prior1YTDDuration | － | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | CurrentYTDDuration | -1754000000 | JPY |
| Payments for acquisition of businesses inv cf IFRS | Prior1YTDDuration | -330000000 | JPY |
| Payments for acquisition of businesses inv cf IFRS | CurrentYTDDuration | － | JPY |
| Proceeds from sale of businesses inv cf IFRS | Prior1YTDDuration | 700000000 | JPY |
| Proceeds from sale of businesses inv cf IFRS | CurrentYTDDuration | － | JPY |
| Purchase of investments accounted for using equity method inv cf IFRS | Prior1YTDDuration | -1449000000 | JPY |
| Purchase of investments accounted for using equity method inv cf IFRS | CurrentYTDDuration | -441000000 | JPY |
| Purchase of investments inv cf IFRS | Prior1YTDDuration | -754000000 | JPY |
| Purchase of investments inv cf IFRS | CurrentYTDDuration | -1045000000 | JPY |
| Proceeds from sale of investments inv cf IFRS | Prior1YTDDuration | 2003000000 | JPY |
| Proceeds from sale of investments inv cf IFRS | CurrentYTDDuration | － | JPY |
| Other inv cf IFRS | Prior1YTDDuration | -464000000 | JPY |
| Other inv cf IFRS | CurrentYTDDuration | -830000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | -9427000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | -11265000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | Prior1YTDDuration | -871000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | CurrentYTDDuration | -265000000 | JPY |
| Proceeds from long term borrowings fin cf IFRS | Prior1YTDDuration | 311348000000 | JPY |
| Proceeds from long term borrowings fin cf IFRS | CurrentYTDDuration | － | JPY |
| Repayments of long term borrowings fin cf IFRS | Prior1YTDDuration | -326760000000 | JPY |
| Repayments of long term borrowings fin cf IFRS | CurrentYTDDuration | -19500000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -4051000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -4335000000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | Prior1YTDDuration | 20826000000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | CurrentYTDDuration | 223000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | Prior1YTDDuration | -359000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |